Let's see improvement in the revenue but virtually no product or maintence money. Very poor guidance IMO for the coming quarters. We will have to pay once the ruling comes out with Digecor but not as much as Digecor was hoping for. No further guidance on future actions against the other 180+/- companies. An almost complete shutdown of the R/D department which speaks volumes, but higher administrative costs. The market is acting with concern .
